Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Sales | 14,061 | 14,002 | 12,019 | 11,573 | 12,561 |
| Cost of Goods | 7,072 | 7,250 | 7,849 | 6,618 | 7,684 |
| Gross Profit | 6,989 | 6,752 | 4,170 | 4,955 | 4,877 |
| Operating Expenses | 5,732 | 7,274 | 7,596 | 7,528 | 8,113 |
| Operating Income | 1,329 | -272 | -2,577 | -1,955 | -2,552 |
| Other Income | 5 | 81 | 58 | -105 | 14 |
| Pre-tax Income | 1,334 | -191 | -2,519 | -2,060 | -2,538 |
| Income Tax | 21 | -82 | 11 | 11 | 28 |
| Net Income Continuous | 1,313 | -109 | -2,530 | -2,071 | -2,566 |
| Net Income | $1,313 | $-109 | $-2,530 | $-2,071 | $-2,566 |
| EPS Basic Total Ops | 0.10 | -0.01 | -0.19 | -0.15 | -0.19 |
| EPS Basic Continuous Ops | 0.10 | -0.01 | -0.19 | -0.15 | -0.19 |
| EPS Diluted Total Ops | 0.09 | -0.01 | -0.19 | -0.15 | -0.19 |
| EPS Diluted Continuous Ops | 0.09 | -0.01 | -0.19 | -0.15 | -0.19 |
| EPS Diluted Before Non-Recurring Items | 0.09 | -0.01 | -0.19 | -0.15 | N/A |
| EBITDA(a) | $1,778 | $185 | $-2,096 | $-1,471 | $-2,107 |